Vor Biopharma Financial Ratios
NASDAQ: VORHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
19.90+0.77 (+4.03%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Vor Biopharma ratio analysis
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Vor Biopharma financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Price / book | — | 0.94 | 20.06 | 20.99 | 35.93 | — |
| Return on equity (ROE) | — | -120.9% | -78.2% | -36.7% | -31.9% | — |
| Return on assets (ROA) | -150.0% | -81.8% | -59.5% | -30.8% | -28.4% | -57.1% |
| Current ratio | 18.20 | 5.19 | 9.04 | 18.06 | 21.12 | 4.81 |